Capital OTC |
Combo Diabetes Treatment Outperforms Others: Study
WebMD The drug belongs to a new class of injectable medications called “glucagon-like peptide-1 agonists” (GLP-1), which mimic the behavior of a gut hormone. It's already available as a treatment for diabetes, either used alone or in combination with basal … Combo Diabetes Therapy Outperforms Other Treatments, Study FindsU.S. News & World Report Combination Diabetes Treatment Better Than Conventional Diabetes …Capital OTC Gut hormone-drug combination therapy may help tackle type 2 diabetesZee News all 18 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.